Clinical Trials： What's on the Horizon？ • Dr. Grewal • 2026 NCF Patient Conference in Atlanta

In this video, Dr. Grewal discusses current and upcoming clinical trials for Neuroendocrine Cancer (both Neuroendocrine Tumors and Neuroendocrine Carcinomas) and explains how research is helping shape the future of neuroendocrine cancer treatment. The talk highlights why clinical trials are important for developing new therapies and expanding treatment options for patients. Dr. Grewal also introduces the “NET wheel,” a helpful tool for understanding the different approaches to neuroendocrine cancer care, including surgery, targeted therapies, PRRT, and clinical trials. Topics include: • Why clinical trials matter in neuroendocrine cancer care • Current and future treatment options for neuroendocrine tumors • Oral somatostatin analogs for carcinoid syndrome • Targeted chemotherapy trials • PRRT and alpha PRRT • CAR-T cell therapy and new treatment targets • Improving access to clinical trials and newer therapies Featured trials and therapies discussed include CareFinder, Brave SST-2, Action One, CDH17-targeted CAR-T cell therapy, and DLL3-targeted therapy for neuroendocrine carcinomas. _____________________________________________________________ ABOUT Neuroendocrine Cancer Patient Education Conference Atlanta, GA May 16, 2026 The Neuroendocrine Cancer Foundation (NCF) hosted a free, in-person educational conference at the Emory Winship Cancer Institute designed specifically for people living with neuroendocrine cancer and their caregivers. This one-day program...